Need Assistance?
  • US & Canada:
    +
  • UK: +

Capistruin

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Capistruin is isolated from Burkholderia thailandensis E264. It exhibits antimicrobial activity against closely related Burkholderia and Pseudomonas strains.

Category
Functional Peptides
Catalog number
BAT-013606
Sequence
GTPGFQTPDARVISRFGFN
1. Insights into the biosynthesis and stability of the lasso peptide capistruin
Thomas A Knappe, Uwe Linne, Lars Robbel, Mohamed A Marahiel Chem Biol. 2009 Dec 24;16(12):1290-8. doi: 10.1016/j.chembiol.2009.11.009.
Capistruin is a 19-residue ribosomally synthesized lasso peptide encoded by the capABCD gene cluster in Burkholderia thailandensis. It is composed of an N-terminal 9-residue macrolactam ring, through which the 10-residue C-terminal tail is threaded. Using a heterologous capistruin production system in Escherichia coli, we have generated 48 mutants of the precursor protein CapA to gain insights into capistruin biosynthesis. Only 4 residues (Gly1, Arg11, Val12, and Ile13) of the lasso sequence were found to be critical for maturation. Tandem mass spectrometric fragmentation studies of capistruin F16A/F18A proved Arg15 to be responsible for the trapping of the C-terminal tail. Substituting Arg15 and Phe16 by alanine revealed a temperature-sensitive capistruin derivative, which unfolds into a branched cyclic peptide upon heating. In conclusion, our global mutagenic approach revealed a low overall specificity of the biosynthetic machinery and important structure-stability correlations.
2. Heterologous Production of Lasso Peptide Capistruin in a Burkholderia Host
Sylvia Kunakom, Alessandra S Eustáquio ACS Synth Biol. 2020 Feb 21;9(2):241-248. doi: 10.1021/acssynbio.9b00438. Epub 2020 Jan 13.
Burkholderia bacteria are an emerging source of natural products with applications in agriculture and medicine. The heterologous expression of biosynthetic gene clusters can streamline natural product discovery; however, production yields with the commonly used Escherichia coli host are usually low. Following the current paradigm that one host does not fit all, we aim to develop a Burkholderia host to ultimately tap into the biosynthetic potential of Burkholderia genomes, which can contain up to 27 biosynthetic gene clusters per genome. Because a close phylogenetic relationship is expected to improve the odds of success due to compatible gene expression and precursor supply, we tested Burkholderia sp. FERM BP-3421, a nonpathogenic isolate previously used to produce natural products at industrial scales. We show here that FERM BP-3421 can produce the model lasso peptide capistruin in yields that are at least 65 times and up to 580 times higher than the previously used E. coli host.
3. Structural mechanism of transcription inhibition by lasso peptides microcin J25 and capistruin
Nathaniel R Braffman, Frank J Piscotta, Jesse Hauver, Elizabeth A Campbell, A James Link, Seth A Darst Proc Natl Acad Sci U S A. 2019 Jan 22;116(4):1273-1278. doi: 10.1073/pnas.1817352116. Epub 2019 Jan 9.
We report crystal structures of the antibacterial lasso peptides microcin J25 (MccJ25) and capistruin (Cap) bound to their natural enzymatic target, the bacterial RNA polymerase (RNAP). Both peptides bind within the RNAP secondary channel, through which NTP substrates enter the RNAP active site, and sterically block trigger-loop folding, which is essential for efficient catalysis by the RNAP. MccJ25 binds deep within the secondary channel in a manner expected to interfere with NTP substrate binding, explaining the partial competitive mechanism of inhibition with respect to NTPs found previously [Mukhopadhyay J, Sineva E, Knight J, Levy RM, Ebright RH (2004) Mol Cell 14:739-751]. The Cap binding determinant on RNAP overlaps, but is not identical to, that of MccJ25. Cap binds further from the RNAP active site and does not sterically interfere with NTP binding, and we show that Cap inhibition is partially noncompetitive with respect to NTPs. This work lays the groundwork for structure determination of other lasso peptides that target the bacterial RNAP and provides a structural foundation to guide lasso peptide antimicrobial engineering approaches.
Online Inquiry
Verification code
Inquiry Basket